Clinical Trials Sponsored by Banner Health

Total 79859 results

Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Mastectomy Flap Temperature Study

Breast Cancer | Mastectomy

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer

Endometrial Cancer

United States
Austin Health
AstraZeneca; Olivia Newton-John Cancer Research Institute

Completed

A Trial of Radiotherapy and Durvalumab in DLBCL and FL (RaDD)

Follicular Lymphoma | Diffuse Large B Cell Lymphoma

Australia
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Secondary Versus Tertiary Wound Closure in High Risk Gynecologic Abdominal Surgical Incisions

Surgical Incision

United States
University Health Network, Toronto
Canadian Breast Cancer Research Alliance

Completed

Effects of Exemestane on Bone Strength (MAP3BSS)

Breast Cancer | Osteoporosis

United States, Canada
OHSU Knight Cancer Institute
Oregon Health and Science University

Active, not recruiting

mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 | Liver and Intrahepatic Bile Duct Carcinoma | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | Unresectable Intrahepatic Cholangiocarcinoma

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Active, not recruiting

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Glioblastoma | Chemoradiation | Cognitive Decline | Radiotherapy; Complications

United States, Guam
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma and other conditions

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Effectiveness and Implementation of mPATH-CRC

Cancer | Colorectal Cancer | Colon Cancer | Rectum Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Active, not recruiting

Understanding and Predicting Breast Cancer Events After Treatment (UPBEAT)

Breast Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

COPD Care Pathway Among Patients With Cancer

Head and Neck Cancer | Chronic Obstructive Pulmonary Disease | Lung Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer | Stage Ib Lung Carcinoma | Stage IIA Lung Carcinoma | Stage IIIA Lung Carcinoma | Stage I Lung Cancer | Stage IA Lung Carcinoma AJCC V7

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Active, not recruiting

Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer (PCW)

Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer

United States, Guam
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Active, not recruiting

Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors

Endometrial Cancer | Survivorship

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Radiation Therapy on Pelvic Floor Disorders in Women (RadPFD)

Colorectal Cancer

United States
Sunnybrook Health Sciences Centre
Ontario Institute for Cancer Research

Terminated

Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer (MA-EEC)

Endometrial Cancer

Canada
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil (Remember)

Cognitive Dysfunction | Memory Impairment

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Chemotherapy-Induced Peripheral Neuropathy

United States
Institute of Cancer Research, United Kingdom
Public Health England

Active, not recruiting

Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)

Cancer

United Kingdom
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia

Endometrial Hyperplasia

United States
Pack Health
Novartis; Ohio State University Comprehensive Cancer Center

Terminated

Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel

Lymphoma, Large B-Cell, Diffuse

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Pain | Breast Cancer | Fatigue | Skin Abnormalities | Radiation Toxicity | Cognitive Ability, General | Psychosocial Deprivation

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer

Recurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Caregiver | Salivary Gland Squamous Cell Carcinoma | Malignant Head and Neck Neoplasm | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Stage... and other conditions

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Terminated

Fibrin Sealant in Preventing Fluid Build Up During Surgery in Patients Undergoing Breast Reconstruction

Breast Cancer | Perioperative/Postoperative Complications

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients

Nonsmall Cell Lung Cancer Stage III | Nonsmall Cell Lung Cancer, Stage II

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

Virtual Reality Experiences for Anxiety and Pain Control

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Human Papillomavirus Infection | Stage IVA Oral Cavity Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma | Stage IVB Oropharyngeal Squamous Cell Carcinoma | Stage IVC Oropharyngeal Squamous Cell Carcinoma | Stage I Oropharyngeal Squamous Cell Carcinoma | Stage II Oropharyngeal... and other conditions

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

Monitoring Blood Flow and Metabolic Activity in Malignant Tissue of Head and Neck Region

Squamous Cell Carcinoma of Head and Neck
Lawson Health Research Institute
Ontario Institute for Cancer Research

Completed

Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy (PICs)

Prostate Cancer

Canada
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Yoga or Educational Wellness Class for Women With Stage I, Stage II, or Stage III Breast Cancer Undergoing Chemotherapy

Depression | Breast Cancer | Fatigue | Sleep Disorders

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

Brain Tumors | Metastatic Disease

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Breast Cancer | Colorectal Cancer | Tobacco Use Disorder | Lung Cancer | Prostate Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL

Leukemia

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Withdrawn

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer

Stage IIB Esophageal Cancer AJCC v7 | Stage III Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer

Anorexia | Lung Cancer | Cachexia

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression

Depression | Unspecified Adult Solid Tumor, Protocol Specific

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas

Pancreatic Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer

Pancreatic Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy

Previously Treated Myelodysplastic Syndromes

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Rural Survivorship Navigation Program (RSVP)

Cancer

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Withdrawn

Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Symptomatic COVID-19 Infection Laboratory-Confirmed
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome

Myelodysplastic Syndromes | Progressive Disease

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Reducing Lung Cancer-Related Anxiety (RELAX) (RELAX)

Lung Cancer

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy

Tobacco Use | Breast Carcinoma | Head and Neck Carcinoma | Lung Carcinoma | Prostate Carcinoma | Caregiver

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease | Metaplasia | Barrett Esophagus | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Dysplasia

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma

Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia

United States
Jonsson Comprehensive Cancer Center
National Institutes of Health (NIH)

Terminated

Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)

Cushing's Disease

United States
Jonsson Comprehensive Cancer Center
National Institutes of Health (NIH)

Completed

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma

Melanoma (Skin)

United States

Clinical Trials Sponsored by Banner Health

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations